Raphael Pharmaceutical, Inc. (RAPH)

1.40 0.00 (0.00%) USD  |  OTCM  |  Feb 06, 16:00
More

Raphael Pharmaceutical EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for RAPH.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
InMode Ltd. Upgrade
Pluri, Inc. Upgrade
BiomX, Inc. Upgrade
IM Cannabis Corp. Upgrade
IR-Med, Inc. Upgrade